E
Revelation Biosciences, Inc. REVB
$3.37 $0.02970.89%
Recommendation
Sell
Prev Close
$3.34
Volume
15,743
Avg Vol (90D)
187,071
Market Cap
$1.74M
Dividend & Yield
--
52-Week Range
$3.19 - $60.80
P/E (TTM)
--
EPS (TTM)
-$268.13
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
E+
Very Weak
Rating Factors
Growth Index
Fair
Efficiency Index
Very Weak
Solvency Index
Good
Total Return Index
Very Weak
Volatility Index
Very Weak
Dividend Index
--
Headlines
Revelation Biosciences GAAP EPS of -$4.98
3/6/2025 - SeekingAlpha.com: All News
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended ...
3/6/2025 - GuruFocus
Revelation Biosciences reports Q4 EPS ($4.98) vs ($133.64) last year
3/6/2025 - The Fly
Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2024
3/6/2025 - Business Wire
Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD ...
2/26/2025 - GuruFocus
Revelation Biosciences Doses First Patient in PRIME Phase 1b Clinical Study of Gemini in CKD Patients
2/26/2025 - Business Wire
Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval
2/24/2025 - GuruFocus
Revelation Biosciences gets continued listing approval from Nasdaq
2/24/2025 - SeekingAlpha.com: All News
Revelation Biosciences gets continued listing approval from Nasdaq
2/24/2025 - Seeking Alpha - Healthcare
Revelation Biosciences receives continued Nasdaq listing approval
2/24/2025 - The Fly
Revelation Biosciences, Inc. Receives Continued NASDAQ Listing Approval
2/24/2025 - Business Wire
Revelation Biosciences Inc trading halted, news pending
1/28/2025 - TipRanks Financial Blog
Revelation Biosciences Inc trading halted, news pending
1/28/2025 - The Fly
Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025
1/24/2025 - GuruFocus
Revelation Biosciences to effect 1-for-16 reverse stock split to regain Nasdaq compliance
1/24/2025 - SeekingAlpha.com: All News
Revelation Biosciences to effect 1-for-16 reverse stock split to regain Nasdaq compliance
1/24/2025 - Seeking Alpha - Healthcare
Revelation Biosciences announces 1-for-16 reverse stock split
1/24/2025 - The Fly
Revelation Biosciences Inc. Announces 1-for-16 Reverse Stock Split Effective January 28, 2025
1/24/2025 - Business Wire
Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients
1/21/2025 - GuruFocus
Revelation Biosciences starts Phase 1b clinical study of Gemini in CKD
1/21/2025 - TipRanks Financial Blog
Revelation Biosciences starts Phase 1b clinical study of Gemini in CKD
1/21/2025 - The Fly
Revelation Biosciences Starts its PRIME Phase 1b Clinical Study of Gemini in CKD Patients
1/21/2025 - Business Wire
Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025
1/13/2025 - GuruFocus
Revelation Biosciences Inc. Reminds You to Vote for the Special Meeting on January 17, 2025
1/13/2025 - Business Wire
Nasdaq grants Revelation Biosciences' request for continued listing
1/6/2025 - Seeking Alpha - Healthcare
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$8.52M
EBIT (TTM)
-$8.55M
Net Income (TTM)
-$15.52M
Balance Sheet
Total Assets (Q)
$6.74M
Total Debt (Q)
$0.00
Total Liabilities (Q)
$4.07M
Book Value Per Share (Q)
$9.97
Cash Flow
Cash from Operations (TTM)
-$16.58M
Cash from Investing (TTM)
-$36.90K
Cash from Financing (TTM)
$9.16M
Net Change in Cash (TTM)
-$7.45M
Filings
Filing Date
Friday, November 8, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Mar 17 and 21 (est)
Price History
Loading...
Beta
0.72
7-Day Total Return
-3.45%
30-Day Total Return
-20.53%
60-Day Total Return
-49.86%
90-Day Total Return
-74.69%
Year to Date Total Return
-67.94%
1-Year Total Return
-93.25%
2-Year Total Return
-99.60%
3-Year Total Return
-99.98%
5-Year Total Return
--
52-week Low
Feb 26, 2025 - $3.19
52-week High
Jun 24, 2024 - $60.80
Valuation
Market Cap
$1.74M - Nano Cap
Enterprise Value
-$4.75M
Price/Sales (TTM)
--
Price/Book (Q)
0.34
Dividends and Shares
Shares Outstanding
167.50K
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.revbiosciences.com
Phone Number
650 800 3717
Address
4660 La Jolla Village Drive
San Diego, CA 92122
Country
United States
Year Founded
2020
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing... more
NASDAQ 03/12/2025 3:13PM Eastern Quotes delayed
Weiss Ratings